Transdermal Nano-Based Drug Delivery Systems for Wound Healing
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 3275
Special Issue Editor
Interests: human skin; keratinocytes; endothelial cells; skin substitutes; stem cells; melanocytes; adipose-dervied stem cells; fat tissue; skin inflammation; immune cells; skin adipocyte progenitors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite the significant progress that has been made in clinical medicine, non-healing wounds such as diabetic foot, venous leg ulcers, pressure ulcers, and other types of injuries propose a serious world health problem. The current limitation for therapies involving proteins, genes, and small molecule drugs has been a delivery system that can effectively enable their full therapeutic benefits. Therefore, innovative drug-delivery systems that are based on nanotechnology for wound treatment have been developed. They can maintain high drug bioactivity bioavailability and can facilitate its release or presentation within the wound at a physiologically relevant rate and duration. In this Special Issue of Pharmaceutics, we aim to highlight recent advances in nanotechnolodgy-based delivery systems for wound healing applications. In particular, we will focus on those systems using hydrogels, scaffolds, biologics, complexes, and coacervates to discuss their advantages and potential drawbacks.
Dr. Agnes Klar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomateriasl
- coacervate
- controlled release
- biologics
- drug delivery
- hydrogel
- microparticles
- scaffold
- wound healing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
